Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C.

@article{Manolakopoulos2010SubstitutionTO,
  title={Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C.},
  author={Spilios G Manolakopoulos and Melanie J Deutsch and Olga Anagnostou and Stelios Karatapanis and Elli Tiniakou and G V Papatheodoridis and Ekaterini Georgiou and Emmanuel K Manesis and Dimitris Tzourmakliotis and Athanasios J. Archimandritis},
  journal={Liver international : official journal of the International Association for the Study of the Liver},
  year={2010},
  volume={30 10},
  pages={1454-60}
}
INTRODUCTION AND AIMS International guidelines and routine clinical practice express concerns about antiviral treatment in intravenous drug users (IDUs). We analysed the effect of IDU and/or substitution therapy on chronic hepatitis C (CHC) treatment adherence and response. PATIENTS AND METHODS Intravenous drug users with CHC were divided into three groups: (A) patients on a substitution programme; (B) active users; and (C) past IDUs. Patients were treated according to the standard of care… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America • 2013

Psychoeducation improves hepatitis C virus treatment during opioid substitution therapy: a controlled, prospective multicenter trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America • 2013

References

Publications referenced by this paper.
Showing 1-10 of 25 references

1051–5

Day JN Nasir AJ Russell SK Vilar FJ. Factors associate Alvarez-Uria G, injecting drug users in the treatment of genotype 2 or 3 hep 2009, 29
Liver International • 2010
View 1 Excerpt

Hepatitis C treatment for injection drug users: a review of the available evidence.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America • 2009

Peginterferon plus Ribavirin for chronic hepatitis C in opiate addicts on methadone/buprenorphine maintenance therapy.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver • 2009

The global burden of hepatitis C.

Liver international : official journal of the International Association for the Study of the Liver • 2009

Similar Papers

Loading similar papers…